Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment - Test2 - elhamkhani - TriplyDB

Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

http://www.wikidata.org/entity/Q23912735

about

Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects Assessment of treatment response in tuberculosis The challenge of chronic lung disease in HIV-infected children and adolescents Urbanization and Daily Exposure to Biomass Fuel Smoke Both Contribute to Chronic Bronchitis Risk in a Population with Low Prevalence of Daily Tobacco Smoking Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease The association between airflow obstruction and radiologic change by tuberculosis A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China S100A12 is up-regulated in pulmonary tuberculosis and predicts the extent of alveolar infiltration on chest radiography: an observational study A systematic review of published literature describing factors associated with tuberculosis recurrence in people living with HIV in Africa Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S New insights into TB physiology suggest untapped therapeutic opportunities Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis Factors associated with abnormal spirometry among HIV-infected individuals The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology Tuberculosis associated pulmonary hypertension: The revelation of a clinical observation Tuberculosis associates with both airflow obstruction and low lung function: BOLD results A novel scoring system to measure radiographic abnormalities and related spirometric values in cured pulmonary tuberculosis Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis The effect of dietary antioxidant on the COPD risk: the community-based KoGES (Ansan-Anseong) cohort Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure Mortality hazard and survival after tuberculosis treatment Clinical significance of low forced expiratory flow between 25% and 75% of vital capacity following treated pulmonary tuberculosis: a cross-sectional study COPD in never smokers: results from the population-based burden of obstructive lung disease study High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena Pulmonary Impairment in Tuberculosis Survivors: The Korean National Health and Nutrition Examination Survey 2008-2012 Factors associated with isolated right heart failure in women: a pilot study from western Kenya Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study Diagnosis and management of miliary tuberculosis: current state and future perspectives Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis Wheeze, asthma diagnosis and medication use: a national adult survey in a developing country

P2860

Q22241773-CAF3DA0D-0118-4718-9797-3ECD4A0C774C Q26206514-A528F704-4C34-4428-9EEC-34C81B31AB84 Q26827746-E12A449B-B29B-4B4A-AEED-3ADFF8BEBD0F Q26850063-65229B50-7F84-4858-9BE1-F61EB01642C3 Q28384421-D5174897-6760-4294-B512-CF32FC6608E4 Q28384616-E7471917-B31B-4F8B-8012-D545919E596A Q28384655-008E6F56-DAF9-44EE-8D1B-C425D6B8D77D Q28384822-7BE5217E-0D34-451A-A619-6FC82103DE94 Q28385486-BD98BCF0-0839-4156-91C6-1785C3F4F863 Q28385694-2C9D2A54-B4A6-47A2-84A1-74326A4893AD Q28385840-39685872-E9F9-423C-B706-6769534ED3C4 Q28386082-A1B2021C-BC27-4A5B-8358-FDA5DA4CD48E Q28387007-B93B0E9F-6C6A-42DD-82F2-20DD0E6EB777 Q28387848-9D155E5D-BD62-4349-B8EF-069AC3BCDE2C Q28387860-7A0BF146-44ED-4AC6-AE0A-F65FB2BF543D Q28388477-E4BBC8C5-9797-45E0-947F-1D6FD4287202 Q28388618-58B6B57C-A471-4009-A8F6-9682250BFD95 Q28388780-9C4663F1-C8D4-4939-8508-755288EC96ED Q28389066-C077BC33-C5EB-4440-813D-AC5B693E8F8D Q28389187-A5A45943-E761-4D97-9753-8C41CBB45725 Q28389802-D2C8D19C-B6E6-4699-A5EF-4FF3B0DFE2B5 Q28389823-4CBC526C-29B7-4FC4-A7B5-C3F577E03AEE Q28389990-30F4C42B-85EF-4022-A30B-20C575DA6C6F Q28390431-353F7879-D8EE-48B8-89B6-FD5B3897B9B5 Q28390507-BF78C38A-7930-456A-9195-0E80D6AE9065 Q28390954-F03CCB17-3122-4795-9E62-55B298F03B8C Q28391035-0EA56F5D-3FC5-4FB6-87EB-8CC115855F5D Q28391110-CC594A76-C7A5-4199-8130-6F5C8C4F5A8D Q28391275-B9E4B0D0-E865-460E-BFC4-27293B5571C6 Q28391658-4B09E8B8-B7EE-4B0C-BF70-3956B114143F Q28391708-0EE7F3D5-CF2E-49B7-8005-5548782EA5A7 Q28391941-B0988AE9-142E-4606-ADF8-5354D4D64842 Q28392067-FBD01F32-08C3-44A6-BF07-4F125012EEED Q28392263-5BDBC3A4-D9AF-43BA-B49A-0F2FD846A8BE Q28392846-36E01BE8-96B6-4E62-AB5C-7AC25DA1E922 Q28393022-07EBF9BE-8976-44BA-8289-FAE12B9A2ED6 Q28393235-5462BB4C-C13A-4BA0-9D0E-BDA6C9BE1D85 Q28393479-1AA23B91-E5EE-47B4-882D-28204936D6A6 Q28393653-BB798CCD-1AC5-4276-8A60-89E7F92E9FE8 Q28394151-755DC53B-9BA0-4C65-874A-10649B633B99

P2860

Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment

http://www.wikidata.org/entity/Q23912735

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Chronic pulmonary function imp ...... berculosis following treatment

@ast

Chronic pulmonary function imp ...... berculosis following treatment

@en

Chronic pulmonary function imp ...... berculosis following treatment

@en-gb

Chronic pulmonary function imp ...... berculosis following treatment

@nl

type

label

Chronic pulmonary function imp ...... berculosis following treatment

@ast

Chronic pulmonary function imp ...... berculosis following treatment

@en

Chronic pulmonary function imp ...... berculosis following treatment

@en-gb

Chronic pulmonary function imp ...... berculosis following treatment

@nl

prefLabel

Chronic pulmonary function imp ...... berculosis following treatment

@ast

Chronic pulmonary function imp ...... berculosis following treatment

@en

Chronic pulmonary function imp ...... berculosis following treatment

@en-gb

Chronic pulmonary function imp ...... berculosis following treatment

@nl

P1433

Q23912735-071655B5-1F6E-40E3-AF52-E2C989D6007E

P1476

Q23912735-B307BAAE-2D5C-4B5C-A709-1826056948FC

P2093

Q23912735-D9F3A1EF-DA07-4A45-BDE1-676F1D4AEDD0

Q23912735-DD6AC2B0-EB55-4178-AE82-83ACF361F23D

Q23912735-EF9DBB7E-B194-4737-B591-C48A01B758D8

P2860

Q23912735-1FA78D93-18DA-4A19-8B73-6C87D2C38ADE

Q23912735-4F3C8138-E648-4B65-BB5A-4D8F42C60940

Q23912735-621679F1-E19A-4946-8216-BBCB505F74F6

Q23912735-670B5B58-6BBC-429A-985C-EC52CB2C517B

Q23912735-679EB862-D745-4A6B-A6C2-D93CF5EAFD53

Q23912735-92D57AB6-DDE5-492B-87AD-17D5C3051A27

Q23912735-9563B70A-EFC2-4C96-8BBC-1CC305145DDD

Q23912735-95E1BF37-6703-4C33-A462-3798DF9F2946

Q23912735-AAB8362A-97FF-497F-B77D-8B18E24A9576

Q23912735-BF34BDB5-5E7F-4FF0-897D-2820F0E51F4F

P2880

Q23912735-AF38B5D6-050D-4D03-9ABC-81CC27194F0C

P304

Q23912735-09DB0FB3-EE5A-48DE-A5D9-414725BE5FA9

P31

Q23912735-8226AA10-9F67-4132-A53E-15396CBDEF53

P3181

Q23912735-F922E384-4B4D-49CD-871A-FF7AE0BD149E

P356

Q23912735-D8300323-5172-40BE-981E-A6869DE4ADCC

P407

Q23912735-C36CC04D-568D-416A-89BF-79D0D0512F43

P433

Q23912735-F0406BA7-9140-4A8E-8EA9-545CFB51F015

P478

Q23912735-AF22B430-FD60-4B86-B0CD-E07D12C60C52

P577

Q23912735-C4D847CC-262E-4987-8201-201006D999A6

P5875

Q23912735-80659DB3-0495-4BB5-802C-1F39B4F28FFB

P698

Q23912735-4BC7D584-E4B8-455D-AC2B-579E3B9CD9E3

P859

Q23912735-8431F515-C0F4-4EAF-9AE4-C35C719F0510

P921

Q23912735-6CCAA107-8E94-4FDF-8632-7BC82EF92C6A

Q23912735-6FDBAB1D-9A25-4152-AB8F-7A2D2D518ADA

Q23912735-8788F7F0-0B5F-48FB-808A-75B4846F7033

Q23912735-9CFEE58D-5BC8-4F50-AF5E-F0B693D790A8

Q23912735-AFF457C9-71D9-4818-8ABE-20BE29351285

Q23912735-CBF0ED03-AD47-4BD6-874C-08538898265C

Q23912735-D7FA9494-7035-45B4-99D1-C5F78A7464D1

P932

Q23912735-25A37BB9-8F84-46FC-B358-B7C6EEE05055

P3181

P356

P1433

P1476

Chronic pulmonary function imp ...... berculosis following treatment

@en

P2093

E Hnizdo

http://www.w3.org/2001/XMLSchema#string

G Churchyard

http://www.w3.org/2001/XMLSchema#string

T Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Variation in incidences of tuberculosis in subgroups of South African gold miners.

The epidemiology of tuberculosis in gold miners with silicosis.

Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners.

Airways obstruction in pulmonary tuberculosis.

Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.

Short-course chemotherapy for silicotuberculosis.

Chronic obstructive airways disease following treated pulmonary tuberculosis.

Spirometry of healthy adult South African men. Part I. Normative values.

Chronic airflow limitation in South African gold miners.

Silicosis, chronic airflow limitation, and chronic bronchitis in South African gold miners.

P2880

20032831

http://www.w3.org/2001/XMLSchema#string

P304

32-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

724370

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/THORAX.55.1.32

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277465908

http://www.w3.org/2001/XMLSchema#string

P698

10607799

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

Akafuba bulwadde

infectious disease

social determinants of health

respiratory tract infection

P932

1745584

http://www.w3.org/2001/XMLSchema#string